Elsevier

Neuroscience Letters

Volume 269, Issue 2, 9 July 1999, Pages 67-70
Neuroscience Letters

Genetic variability at the amyloid-β precursor protein locus may contribute to the risk of late-onset Alzheimer's disease

https://doi.org/10.1016/S0304-3940(99)00417-6Get rights and content

Abstract

In a series of sibpairs with late onset Alzheimer's disease, we have examined the segregation of the loci involved in the early onset, autosomal dominant form of the disorder by using flanking microsatellite repeat markers: thus we have used APP-PCR3 and D21S210 to examine the segregation of the amyloid-β precursor protein (APP) gene, the markers Dl 4S77 and D14S284 to examine the segregation of the presenilin 1 (PSI) gene and the markers D1S227, D1S249 and D1S419 to examine the segregation of presenilin 2 (PS2). We carried out our analyses on the whole dataset of 291 affected sibpairs, and on subsets comprising those sibpairs in which neither had an apolipoprotein E4 allele (65 affected sibpairs) and those in which both had an apolipoprotein E4 allele (165 affected sibpairs). We used the programs SPLINK to generate allele frequencies and MAPMAKER/SIBS to analyze our results. We examined the segregation of the markers D19S908 and D19S918 that are close to the apolipoprotein E (ApoE) gene as a positive control to assess whether the methods we are employing have the capability to identify known loci. The sibpair approach to the identification of genetic risk loci is relatively insensitive as indicated by the failure of the ApoE locus to reach statistical significance (P=0.06). Nevertheless, these data suggest that neither the PS1 nor the PS2 gene is a major locus for late-onset AD, but that the APP gene cannot be ruled out as a risk locus in those sibships without an E4 allele (P=0.014). The possibility that APP is indeed a locus for late onset disease will need confirmation in other series of familial cases.

Section snippets

Acknowledgements

This work was supported by the Medical Research Council (UK), the Mayo Foundation, the National Institute of Health, the Alzheimer's Disease Association and the Nettie and Rebecca Brown Foundation. The samples were collected as part of the NIMH Alzheimer's genetic initiative (Ref. [2]).

References (28)

  • D. Blacker et al.

    ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative

    Neurology

    (1997)
  • M.C. Chartier-Harlin et al.

    Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region

    Hum. Mol. Genet.

    (1994)
  • E.H. Corder et al.

    Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

    Science

    (1993)
  • B. De Strooper et al.

    Deficiency of presenilin-l inhibits the normal cleavage of amyloid precursor protein

    Nature

    (1998)
  • Cited by (41)

    • Markers of neural degeneration and regeneration in Down syndrome patients

      2013, Egyptian Journal of Medical Human Genetics
      Citation Excerpt :

      The significant increase in Aβ42 in DS compared to controls in the present study is due to the APP gene, located on the long arm of extra expressed chromosome 21 [5,7,24]. Aß42 progressively accumulates in the brain as neuritic plaques contributing to the association of dementia in DS and AD [25,26] and age-dependent cognitive sequelae [27,28]. The significant increase of Aβ42 among adolescent DS compared to young DS gives an indication that Aβ42 increases by aging in DS patients.

    View all citing articles on Scopus
    View full text